comparemela.com

Latest Breaking News On - Eyepoint pharmaceuticals stock down - Page 1 : comparemela.com

StockNews.com Downgrades EyePoint Pharmaceuticals (NASDAQ:EYPT) to Sell

StockNews.com Downgrades EyePoint Pharmaceuticals (NASDAQ:EYPT) to Sell
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Vanguard-group-inc
Hermes-inc
Eyepoint-pharmaceuticals
Eyepoint-pharmaceuticals-inc
Jennison-associates
Institutional-investors-weigh-in-on-eyepoint-pharmaceuticals
Securities-exchange-commission
Jpmorgan-chase-co
Eyepoint-pharmaceuticals-company-profile
Eyepoint-pharmaceuticals-stock-down
News-ratings-for-eyepoint-pharmaceuticals-daily

Brokerages Set EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Price Target at $33.86

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has received an average recommendation of “Buy” from the seven brokerages that are presently covering the stock, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year […]

United-states
American
Darioa-paggiarino
Tower-research-capital
Securities-exchange-commission
Analyst-recommendations-for-eyepoint-pharmaceuticals
Institutional-investors-weigh-in-on-eyepoint-pharmaceuticals
American-international-group-inc
Nasdaq
News-ratings-for-eyepoint-pharmaceuticals-daily
Investment-advisers

Legato Capital Management LLC Has $1.37 Million Stake in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)

Legato Capital Management LLC lessened its holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 23.3% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 59,347 shares of the company’s stock after selling 18,054 shares during the period. Legato Capital Management LLC owned […]

Darioa-paggiarino
News-ratings-for-eyepoint-pharmaceuticals-daily
Nasdaq
Quarter-for-eyepoint-pharmaceuticals
Investment-advisers
Eyepoint-pharmaceuticals
Securities-exchange-commission
Jpmorgan-chase-co
Toth-financial-advisory-corp
Lazard-asset-management
Eyepoint-pharmaceuticals-inc

Legato Capital Management LLC Sells 18,054 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)

Legato Capital Management LLC trimmed its holdings in shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 23.3% during the fourth quarter, HoldingsChannel reports. The fund owned 59,347 shares of the company’s stock after selling 18,054 shares during the quarter. Legato Capital Management LLC’s holdings in EyePoint Pharmaceuticals were worth $1,372,000 at the end […]

Darioa-paggiarino
Eyepoint-pharmaceuticals-company-profile
Eyepoint-pharmaceuticals-stock-down
Legato-capital-management
Goldman-sachs-group-inc
Insider-activity-at-eyepoint-pharmaceuticals
Jpmorgan-chase-co
Vanguard-group-inc
Eyepoint-pharmaceuticals-inc
News-ratings-for-eyepoint-pharmaceuticals-daily
Nasdaq

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Down to $24.40

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Down to $24.40
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Darioa-paggiarino
Toth-financial-advisory-corp
Investment-advisers
Nasdaq
Jpmorgan-chase-co
Insider-activity-at-eyepoint-pharmaceuticals
News-ratings-for-eyepoint-pharmaceuticals-daily
Tower-research-capital
Eyepoint-pharmaceuticals-stock-down
Schonfeld-strategic-advisors
Eyepoint-pharmaceuticals

vimarsana © 2020. All Rights Reserved.